VERTEX PHARMACEUTICALS INC (VRTX) Stock Earnings Estimates
NASDAQ:VRTX • US92532F1003
496.83 USD
+16.7 (+3.48%)
At close: Feb 27, 2026
496.83 USD
0 (0%)
After Hours: 2/27/2026, 8:00:02 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.869B 10.51% | 11.02B 11.66% | 12.001B 8.90% | 13.333B 11.10% | 14.697B 10.23% | 16.365B 11.35% | 17.533B 7.14% | 18.948B 8.07% | 20.474B 8.05% | 22.135B 8.11% | 23.651B 6.85% | |
| EBITDA YoY % growth | 4.54B -0.96% | 4.603B 1.37% | N/A 22.04% | 5.741B 2.21% | 6.786B 18.20% | 7.702B 13.50% | 8.591B 11.54% | 9.436B 9.84% | 10.293B 9.08% | 12.19B 18.43% | 12.636B 3.66% | |
| EBIT YoY % growth | 4.359B -1.73% | 4.396B 0.84% | 4.685B 6.59% | 5.597B 19.46% | 6.488B 15.92% | 7.31B 12.67% | 8.943B 22.34% | 9.865B 10.31% | 10.858B 10.07% | 12.304B 13.32% | 13.076B 6.27% | |
| Operating Margin | 44.17% | 39.89% | 39.04% | 41.98% | 44.15% | 44.67% | 51.01% | 52.06% | 53.03% | 55.59% | 55.29% | |
| EPS YoY % growth | 15.22 2.22% | 0.29 -98.09% | 18.41 6,248.28% | 20.39 10.74% | 22.88 12.24% | 25.06 9.52% | 29.25 16.70% | 32.16 9.97% | 35.44 10.18% | 40.05 13.03% | 42.92 7.17% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 4.48 10.33% | 4.81 6.39% | 5.16 7.57% | 5.24 4.12% |
| Revenue Q2Q % growth | 3.127B 12.88% | 3.28B 10.64% | 3.335B 8.41% | 3.389B 6.24% |
| EBITDA Q2Q % growth | 1.376B 27.73% | 1.443B 15.13% | 1.544B 10.70% | 1.491B -2.87% |
| EBIT Q2Q % growth | 1.269B 23.34% | 1.371B 18.88% | 968.29M -21.96% | 1.473B 16.68% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 5.03 26.38% | 5.17 | -0.14 | -2.79% |
| Q3 2025 Q2Q % growth | 4.80 9.59% | 4.65 | 0.15 | 3.12% |
| Q2 2025 Q2Q % growth | 4.52 135.23% | 4.37 | 0.15 | 3.45% |
| Q1 2025 Q2Q % growth | 4.06 -14.71% | 4.37 | -0.31 | -7.20% |
| Q4 2024 Q2Q % growth | 3.98 -5.24% | 4.11 | -0.13 | -3.07% |
| Q3 2024 Q2Q % growth | 4.38 7.35% | 4.22 | 0.16 | 3.69% |
| Q2 2024 Q2Q % growth | -12.83 -429.82% | 3.00 | -15.83 | -527.57% |
| Q1 2024 Q2Q % growth | 4.76 56.07% | 4.14 | 0.62 | 14.85% |
| Q4 2023 Q2Q % growth | 4.20 11.70% | 4.18 | 0.02 | 0.36% |
| Q3 2023 Q2Q % growth | 4.08 1.75% | 4.05 | 0.03 | 0.66% |
| Q2 2023 Q2Q % growth | 3.89 8.06% | 3.96 | -0.07 | -1.75% |
| Q1 2023 Q2Q % growth | 3.05 -13.35% | 3.06 | -0.01 | -0.21% |
| Q4 2022 Q2Q % growth | 3.76 11.57% | 3.58 | 0.18 | 4.95% |
| Q3 2022 Q2Q % growth | 4.01 12.64% | 3.72 | 0.29 | 7.89% |
| Q2 2022 Q2Q % growth | 3.60 15.76% | 3.55 | 0.05 | 1.44% |
| Q1 2022 Q2Q % growth | 3.52 18.12% | 3.56 | -0.04 | -1.18% |
| Q4 2021 Q2Q % growth | 3.37 34.26% | 3.37 | 0.00 | 0.13% |
| Q3 2021 Q2Q % growth | 3.56 34.85% | 3.14 | 0.42 | 13.27% |
| Q2 2021 Q2Q % growth | 3.11 19.16% | 2.56 | 0.55 | 21.59% |
| Q1 2021 Q2Q % growth | 2.98 16.41% | 2.74 | 0.24 | 8.66% |
| Q4 2020 Q2Q % growth | 2.51 | 2.64 | -0.13 | -5.00% |
| Q3 2020 Q2Q % growth | 2.64 | 2.39 | 0.25 | 10.49% |
| Q2 2020 Q2Q % growth | 2.61 | 2.12 | 0.49 | 23.38% |
| Q1 2020 Q2Q % growth | 2.56 | 1.88 | 0.68 | 36.03% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 3.19B 9.55% | 3.239B | -49M | -1.51% |
| Q3 2025 Q2Q % growth | 3.076B 10.99% | 3.114B | -37.6M | -1.21% |
| Q2 2025 Q2Q % growth | 2.965B 12.06% | 2.963B | 1.7M | 0.06% |
| Q1 2025 Q2Q % growth | 2.77B 2.96% | 2.91B | -139.8M | -4.80% |
| Q4 2024 Q2Q % growth | 2.912B 15.66% | 2.836B | 76M | 2.68% |
| Q3 2024 Q2Q % growth | 2.772B 11.61% | 2.778B | -6.1M | -0.22% |
| Q2 2024 Q2Q % growth | 2.646B 6.11% | 2.715B | -69.4M | -2.56% |
| Q1 2024 Q2Q % growth | 2.691B 13.30% | 2.63B | 60.6M | 2.30% |
| Q4 2023 Q2Q % growth | 2.518B 9.34% | 2.564B | -46.3M | -1.81% |
| Q3 2023 Q2Q % growth | 2.484B 6.39% | 2.55B | -66.5M | -2.61% |
| Q2 2023 Q2Q % growth | 2.493B 13.52% | 2.468B | 25.2M | 1.02% |
| Q1 2023 Q2Q % growth | 2.375B 13.22% | 2.384B | -9.2M | -0.39% |
| Q4 2022 Q2Q % growth | 2.303B 11.10% | 2.347B | -44.3M | -1.89% |
| Q3 2022 Q2Q % growth | 2.334B 17.65% | 2.271B | 63.3M | 2.79% |
| Q2 2022 Q2Q % growth | 2.196B 22.46% | 2.175B | 21.2M | 0.97% |
| Q1 2022 Q2Q % growth | 2.098B 21.64% | 2.118B | -20.5M | -0.97% |
| Q4 2021 Q2Q % growth | 2.073B 27.32% | 2.043B | 29.561M | 1.45% |
| Q3 2021 Q2Q % growth | 1.984B 28.99% | 1.893B | 91.164M | 4.82% |
| Q2 2021 Q2Q % growth | 1.793B 17.64% | 1.752B | 41.37M | 2.36% |
| Q1 2021 Q2Q % growth | 1.724B 13.81% | 1.69B | 34.305M | 2.03% |
| Q4 2020 Q2Q % growth | 1.628B | 1.616B | 11.82M | 0.73% |
| Q3 2020 Q2Q % growth | 1.538B | 1.515B | 23.271M | 1.54% |
| Q2 2020 Q2Q % growth | 1.524B | 1.413B | 111.485M | 7.89% |
| Q1 2020 Q2Q % growth | 1.515B | 1.313B | 202.107M | 15.39% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.41% | -0.58% | 0.15% | -1.34% |
| Revenue | -0.22% | -0.15% | 0.47% | -0.46% |